Search | TVST | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles May 2022

Characterization and Validation of In Vitro and In Vivo Models to Investigate TNF-α-Induced Inflammation in Retinal Diseases

PDF

Carina M. Weigelt; Nina Zippel; Holger Fuchs; Anna-Kaisa Rimpelä; Tanja Schönberger; Birgit Stierstorfer; Remko A. Bakker; Norbert H. Redemann
TAGS: golimumab, inflammation, mice, retinal diseases, tumor necrosis factors
Trans. Vis. Sci. Tech.. 2022; 11(5):18. doi: https://doi.org/10.1167/tvst.11.5.18

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Predicting intravitreal clearance of small-molecule drugs using Caco-2 permeability as a surrogate for ocular tissue permeability

Anna-Kaisa Rimpelä; Yunhai Cui; Achim Sauer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1188. doi:

ARVO Annual Meeting Abstract June 2020

A novel method for isolating rat eye substructures for measuring drug concentrations in different ocular target tissues

Anna-Kaisa Rimpelä; Michel Garneau; Katja Baum-Kroker; Achim Sauer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):33. doi:

ARVO Annual Meeting Abstract September 2016

Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics and SPECT/CT imaging

Anna-Kaisa Rimpelä; Mechthild Schmitt; Satu Latonen; Marja Hagström; Maxim Antopolsky; José Antonio Manzanares; Heidi Kidron; Arto Urtti

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):107. doi:

Advertisement